260 related articles for article (PubMed ID: 22053213)
21. RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.
Fomenkov A; Zangen R; Huang YP; Osada M; Guo Z; Fomenkov T; Trink B; Sidransky D; Ratovitski EA
Cell Cycle; 2004 Oct; 3(10):1285-95. PubMed ID: 15467455
[TBL] [Abstract][Full Text] [Related]
22. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.
Fukushima H; Koga F; Kawakami S; Fujii Y; Yoshida S; Ratovitski E; Trink B; Kihara K
Cancer Res; 2009 Dec; 69(24):9263-70. PubMed ID: 19934319
[TBL] [Abstract][Full Text] [Related]
23. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
[TBL] [Abstract][Full Text] [Related]
24. ΔNp63α activates CD82 metastasis suppressor to inhibit cancer cell invasion.
Wu J; Liang S; Bergholz J; He H; Walsh EM; Zhang Y; Xiao ZX
Cell Death Dis; 2014 Jun; 5(6):e1280. PubMed ID: 24901051
[TBL] [Abstract][Full Text] [Related]
25. Global tumor protein p53/p63 interactome: making a case for cisplatin chemoresistance.
Huang Y; Jeong JS; Okamura J; Sook-Kim M; Zhu H; Guerrero-Preston R; Ratovitski EA
Cell Cycle; 2012 Jun; 11(12):2367-79. PubMed ID: 22672905
[TBL] [Abstract][Full Text] [Related]
26. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
27. DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.
Higashikawa K; Yoneda S; Tobiume K; Saitoh M; Taki M; Mitani Y; Shigeishi H; Ono S; Kamata N
Int J Cancer; 2009 Jun; 124(12):2837-44. PubMed ID: 19267405
[TBL] [Abstract][Full Text] [Related]
28. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
Jeon YJ; Jo MG; Yoo HM; Hong SH; Park JM; Ka SH; Oh KH; Seol JH; Jung YK; Chung CH
J Clin Invest; 2012 Jul; 122(7):2622-36. PubMed ID: 22706304
[TBL] [Abstract][Full Text] [Related]
29. Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition.
Kadera BE; Toste PA; Wu N; Li L; Nguyen AH; Dawson DW; Donahue TR
Clin Cancer Res; 2015 Jan; 21(1):157-65. PubMed ID: 25348515
[TBL] [Abstract][Full Text] [Related]
30. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
31. deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes.
King KE; Ponnamperuma RM; Yamashita T; Tokino T; Lee LA; Young MF; Weinberg WC
Oncogene; 2003 Jun; 22(23):3635-44. PubMed ID: 12789272
[TBL] [Abstract][Full Text] [Related]
32. Regulation of ΔNp63α by NFκΒ.
Sen T; Chang X; Sidransky D; Chatterjee A
Cell Cycle; 2010 Dec; 9(24):4841-7. PubMed ID: 21088498
[TBL] [Abstract][Full Text] [Related]
33. Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.
Mundt HM; Stremmel W; Melino G; Krammer PH; Schilling T; Müller M
Biochem Biophys Res Commun; 2010 May; 396(2):335-41. PubMed ID: 20403333
[TBL] [Abstract][Full Text] [Related]
34. 14-3-3σ (sigma) regulates proliferation and differentiation of multipotent p63-positive cells isolated from human breastmilk.
Thomas E; Zeps N; Cregan M; Hartmann P; Martin T
Cell Cycle; 2011 Jan; 10(2):278-84. PubMed ID: 21239874
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
36. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.
King KE; Ponnamperuma RM; Allen C; Lu H; Duggal P; Chen Z; Van Waes C; Weinberg WC
Cancer Res; 2008 Jul; 68(13):5122-31. PubMed ID: 18593911
[TBL] [Abstract][Full Text] [Related]
37. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH
Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964
[TBL] [Abstract][Full Text] [Related]
38. Loss of ΔNp63α promotes mitotic exit in epithelial cells.
Hau PM; Yip YL; Huen MS; Tsao SW
FEBS Lett; 2011 Sep; 585(17):2720-6. PubMed ID: 21821031
[TBL] [Abstract][Full Text] [Related]
39. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
[TBL] [Abstract][Full Text] [Related]
40. Targeting of ΔNp63α by miR-522 promotes the migration of breast epithelial cells.
Dong Y; Long J; Luo X; Xie G; Xiao ZJ; Tong Y
FEBS Open Bio; 2021 Feb; 11(2):468-481. PubMed ID: 33369228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
